BS Kramer, ML Brown, PC Prorok, AL … - Annals of internal medicine, 1993 - Am Coll Physicians From the Division of Cancer Prevention and Control, National Cancer Institute,
Bethesda, Maryland. Acknowledgments: The authors thank Drs. Paul Schellhammer
(urology), Ian Thompson (urology), Donald Henson (pathology), and Peter ... Cited by 262 - Related articles - BL Direct - All 4 versions
SA Optenberg, IM Thompson - The Urologic clinics of North America, 1990 - ncbi.nlm.nih.gov The proposition of whether to adopt a system of mass screening for carcinoma of
the prostate in the US is well suited to the clinical decision analysis
approach. The authors demonstrate this by using available data, which ... Cited by 123 - Related articles
MD Krahn, JE Mahoney, MH Eckman, J … - Jama, 1994 - Am Med Assoc OBJECTIVE--To determine the clinical and economic effects of screening for
prostate cancer with prostate-specific antigen (PSA), transrectal ultrasound
(TRUS), and digital rectal examination (DRE). DESIGN--Decision analytic ... Cited by 312 - Related articles - BL Direct - All 4 versions
VJ Dorr, SK Williamson, RL Stephens - Archives of Internal Medicine, 1993 - archinte.highwire.org Adenocarcinoma of the prostate is ex¬ pected in 1992 to affect 132 000 men and
to cause 34 000 deaths in men older than 50 years.This will make prostate cancer
the most commonly diagnosed cancer in American males, accounting for 23% of ... Cited by 51 - Related articles - BL Direct - All 4 versions
PC Walsh - Annals of internal medicine, 1993 - Am Coll Physicians To reduce the number of deaths from prostate cancer, there are four approaches:
primary prevention, early diagnosis, effective treatment of curable disease, and
improved management of advanced disease. In the foreseeable future, it is ... Cited by 51 - Related articles - BL Direct - All 4 versions
SH Woolf - The New England journal of medicine, 1995 - nejm.highwire.org The debate about whether to perform PSA screening has important implications for
both individual and public health, but the setting of appropriate policy has
been hindered by inadequate data. Screening may reduce morbidity and ... Cited by 219 - Related articles - BL Direct - All 5 versions
C Fleming, JH Wasson, PC Albertsen, MJ … - Jama, 1993 - Am Med Assoc OBJECTIVE--To model the impact of initial therapy on outcomes for men with
localized (clinical stage A or B) prostatic carcinoma. DESIGN--A decision
analysis modeling three strategies: radical prostatectomy, external-beam ... Cited by 408 - Related articles - BL Direct - All 4 versions
JW Mold, DR Holtgrave, RS Bisonni, DS … - The Journal of family practice, 1992 - ncbi.nlm.nih.gov BACKGROUND. Whether to perform periodic rectal examinations in asymptomatic men
as a screening test for prostatic cancer remains controversial. A randomized
clinical trial that tests the efficacy of further evaluation and treatment ... Cited by 42 - Related articles - All 2 versions
AL Potosky, BA Miller, PC Albertsen, BS … - Jama, 1995 - Am Med Assoc OBJECTIVE--To assess the reasons for the dramatic surge in prostate cancer
incidence from 1986 to 1991. DESIGN--Population-based study of incidence rates
and procedures used to detect and diagnose prostate cancer derived from ... Cited by 429 - Related articles - BL Direct - All 4 versions
JE Johansson, HO Adami, SO Andersson, R … - Jama, 1992 - Am Med Assoc OBJECTIVE--To learn about the natural history of untreated, early-stage
prostatic cancer. DESIGN--Cohort study with a mean follow-up of 123 months
(range, 81 to 165 months). SETTING--Population-based, regionally well ... Cited by 349 - Related articles - All 3 versions
